Evaluation of Safety, Rate and Extent of Absorption of Psilocin Mucate

计划入组 10 人 · 首次发布于 2023 年 9 月 13 日

Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

计划入组 20 人 · 首次发布于 2022 年 4 月 8 日

Ultrasongraphy Versus Fluoroscopy in Lumber Sympathetic Block in Chronic Lower Limb Ischemia

计划入组 60 人 · 首次发布于 2023 年 10 月 10 日

L-130

Soquinolol Mucate

Dexisometheptene mucate

C₉H₁₉N

CLEVELAND CLINIC ABUDHABI L L C

United Arab Emirates

ARNOLD, L EUGENE

United States

Robb, Geoffrey L

United States

Lobe Sciences Advances L-130 for Chronic Cluster Headache and S-100 for Sickle Cell Disease, Targets Late 2026 IND Filing

Lobe Sciences to Present Phase 1a Low-Dose Psilocin Data for L-130 at Neuropsychiatric Drug Development Summit

Tryptamine Therapeutics Progresses Psilocin Drug Trials for Treatment-Resistant Depression